Medpace Holdings, Inc. (NAS: MEDP) Stock Analysis & Fundamentals | ScreenerHero

Create free account

MEDPMedpace Holdings, Inc.

NAS · US · Healthcare · Diagnostics & Research · medpace.com

529.59USD-0.96%Mkt Cap: 15.12B $P/E: 33.351d ago

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/E

Avg

P/B

Pricier

1M Perf

Lower

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap15.12B $

Enterprise Value14.62B $

Revenue (TTM)2.68B $

Gross Profit760.62M $

Net Income (TTM)451.12M $

Revenue/Share94.44 USD

Last Price529.59 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees6.3K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS58506Q1094

Valuation

P/E (Trailing)33.35

P/E (Forward)28.23

PEG3.23

EV/EBITDA24.73

EV/Revenue5.46

P/S5.65

P/B25.28

EPS (TTM)15.88

EPS (Forward)18.76

52W Range

306.7069% of range628.92

52W High628.92 USD

52W Low306.70 USD

Profitability

Gross Margin30.06%

Oper. Margin20.03%

EBITDA Margin22.07%

Profit Margin17.83%

ROE98.27%

ROA22.84%

Growth

Revenue Growth26.50%

Earnings Growth16.60%

Cash Flow & Leverage

Operating CF713.22M $

CapEx (TTM)31.36M $

FCF Margin18.32%

FCF Yield3.24%

Net Debt-506.59M $

Net Debt/EBITDA-0.86

Balance Sheet

Debt/Equity0.25

Current Ratio0.85

Quick Ratio0.78

Book Value/Sh20.95 USD

Cash/Share22.85 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.6 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)443.50 USD

Upside (mean)-16.3%

Target Range329.00 USD – 495.00 USD

$329.00-16.3% to mean$495.00

# Analysts12

Ownership

Shares Out.28.56M

Float23.00M

Insiders19.43%

Institutions88.62%

Short Interest

Short Ratio7.5d

Short % Float9.06%

Short % Out.7.31%

Shares Short2.09M

Short (prev mo.)1.90M

Technical

SMA 50450.41 (+17.6%)

SMA 200513.06 (+3.2%)

Beta1.18

S&P 52W Chg20.05%

Avg Vol (30d)274.23K

Avg Vol (10d)359.60K

Technical Indicators

RSI (14)74.8

MACD20.7517

MACD Signal13.3541

MACD Hist.+7.3976

BB Upper536.02 USD

BB Middle477.00 USD

BB Lower417.98 USD

BB Width24.75%

ATR (14)17.48 USD

Vol Ratio (20d)1.11x